These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29618495)

  • 21. Fixed Handheld Dynamometry Provides Reliable and Valid Values for Quadriceps Isometric Strength in People With Chronic Obstructive Pulmonary Disease: A Multicenter Study.
    Bui KL; Mathur S; Dechman G; Maltais F; Camp P; Saey D
    Phys Ther; 2019 Sep; 99(9):1255-1267. PubMed ID: 30939198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary rehabilitation, physical activity and aortic stiffness in COPD.
    Aldabayan YS; Ridsdale HA; Alrajeh AM; Aldhahir AM; Lemson A; Alqahtani JS; Brown JS; Hurst JR
    Respir Res; 2019 Jul; 20(1):166. PubMed ID: 31340825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quadriceps muscle fat infiltration is associated with cardiometabolic risk in COPD.
    Vivodtzev I; Moncharmont L; Tamisier R; Borel JC; Arbib F; Wuyam B; Lévy P; Maltais F; Ferretti G; Pépin JL
    Clin Physiol Funct Imaging; 2018 Sep; 38(5):788-797. PubMed ID: 29105276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?
    Puig-Vilanova E; Ausin P; Martinez-Llorens J; Gea J; Barreiro E
    PLoS One; 2014; 9(7):e102296. PubMed ID: 25013984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
    Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
    Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.
    Spruit MA; Gosselink R; Troosters T; Kasran A; Gayan-Ramirez G; Bogaerts P; Bouillon R; Decramer M
    Thorax; 2003 Sep; 58(9):752-6. PubMed ID: 12947130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airflow obstruction was associated with elevation of brachial-ankle pulse wave velocity but not ankle-brachial index in aged patients with chronic obstructive pulmonary disease.
    Chen R; He W; Zhang K; Zheng H; Lin L; Nie R; Wang J; Huang H
    Atherosclerosis; 2015 Sep; 242(1):135-40. PubMed ID: 26188536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.
    Bhatt SP; Dransfield MT; Cockcroft JR; Wang-Jairaj J; Midwinter DA; Rubin DB; Scott-Wilson CA; Crim C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():351-365. PubMed ID: 28176907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voluntary activation during knee extensions in severely deconditioned patients with chronic obstructive pulmonary disease: benefit of endurance training.
    Vivodtzev I; Flore P; Lévy P; Wuyam B
    Muscle Nerve; 2008 Jan; 37(1):27-35. PubMed ID: 17912747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach.
    Boyer L; Bastuji-Garin S; Chouaid C; Housset B; Le Corvoisier P; Derumeaux G; Boczkowski J; Maitre B; Adnot S; Audureau E
    Sci Rep; 2018 Jun; 8(1):8569. PubMed ID: 29872127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound Evaluation of the Quadriceps Muscle Contractile Index in Patients with Stable Chronic Obstructive Pulmonary Disease: Relationships with Clinical Symptoms, Disease Severity and Diaphragm Contractility.
    Maynard-Paquette AC; Poirier C; Chartrand-Lefebvre C; Dubé BP
    Int J Chron Obstruct Pulmon Dis; 2020; 15():79-88. PubMed ID: 32021146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease.
    Troosters T; Probst VS; Crul T; Pitta F; Gayan-Ramirez G; Decramer M; Gosselink R
    Am J Respir Crit Care Med; 2010 May; 181(10):1072-7. PubMed ID: 20133927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerobic exercise training does not alter vascular structure and function in chronic obstructive pulmonary disease.
    Gelinas JC; Lewis NC; Harper MI; Melzer B; Agar G; Rolf JD; Eves ND
    Exp Physiol; 2017 Nov; 102(11):1548-1560. PubMed ID: 28857336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study.
    Fermont JM; Fisk M; Bolton CE; MacNee W; Cockcroft JR; Fuld J; Cheriyan J; Mohan D; Mäki-Petäjä KM; Al-Hadithi AB; Tal-Singer R; Müllerova H; Polkey MI; Wood AM; McEniery CM; Wilkinson IB;
    BMJ Open; 2020 Dec; 10(12):e038360. PubMed ID: 33372069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial.
    Sillen MJ; Franssen FM; Delbressine JM; Vaes AW; Wouters EF; Spruit MA
    Thorax; 2014 Jun; 69(6):525-31. PubMed ID: 24399630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular Risk in COPD: Deciphering the Contribution of Tobacco Smoking.
    Soumagne T; Roche N; Guillien A; Bouhaddi M; Rocchi S; Hue S; Claudé F; Bizard L; Andujar P; Dalphin JC; Degano B
    Chest; 2020 Apr; 157(4):834-845. PubMed ID: 31759959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of three different equations for predicting quadriceps femoris muscle strength in patients with COPD.
    Nellessen AG; Donária L; Hernandes NA; Pitta F
    J Bras Pneumol; 2015; 41(4):305-12. PubMed ID: 26398750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine profile in quadriceps muscles of patients with severe COPD.
    Barreiro E; Schols AM; Polkey MI; Galdiz JB; Gosker HR; Swallow EB; Coronell C; Gea J;
    Thorax; 2008 Feb; 63(2):100-7. PubMed ID: 17875568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care.
    Kelly JL; Elkin SL; Fluxman J; Polkey MI; Soljak MA; Hopkinson NS
    COPD; 2013 Feb; 10(1):40-54. PubMed ID: 23272667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.